{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "The Arts/Cultural Desk", "lead_paragraph": "The 2002-3 season for the Roundabout Theater Company has been a critical success, including ''Tartuffe'' and ''A Day in the Death of Joe Egg,'' as well as the season's hottest musical revival, ''Nine,'' starring Antonio Banderas. ''Nine'' won two Tony Awards and has been regularly packing the Eugene O'Neill Theater. But without a doubt, that season has also been a financial disappointment for the company. Hurt by a weak economy, reduced subscriptions and overall decline in philanthropic giving, the company posted its first yearly loss in more than two decades -- a $2 million shortfall that may well be addressed with staff reductions, productions with smaller casts and salary freezes.", "headline": {"main": "An Expanding Theater and a Healing Director"}, "abstract": "Article on Roundabout Theater Company's 2002-03 season, which featured critically acclaimed plays but $2 million shortfall, its first yearly loss in more than two decades; also during this period, artistic director Todd Haimes underwent treatment for sarcoma of the jaw; Haimes comments on surgery, chemotherapy and company's artistic and financial status; photos (M)", "print_page": "1", "word_count": 1488, "_id": "4fd275738eb7c8105d834dbc", "snippet": "The 2002-3 season for the Roundabout Theater Company has been a critical success, including ''Tartuffe'' and ''A Day in the Death of Joe Egg,'' as well as the season's hottest musical revival, ''Nine,'' starring Antonio Banderas. ''Nine'' won two...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/07/23/theater/an-expanding-theater-and-a-healing-director.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "HAIMES, TODD"}, {"name": "organizations", "value": "ROUNDABOUT THEATER CO"}, {"name": "subject", "value": "JAW (BODY PART)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "THEATER"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Jesse", "lastname": "McKINLEY"}], "original": "By JESSE McKINLEY"}, "document_type": "article", "pub_date": "2003-07-23T00:00:00Z", "section_name": "Arts; Theater"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The number of people retiring with health insurance from their employers has dropped significantly since 1996, according to a new study, leaving many recent retirees without coverage for prescription drugs. The study, which was conducted from interviews of Medicare beneficiaries 65 to 69 years old, appears today on the Web site of Health Affairs, an academic journal.", "headline": {"main": "Fewer Retirees Are Receiving Drug Benefits From Employers"}, "abstract": "Study finds that while overall percentage of Medicare beneficiaries with employer-sponsored health insurance held relatively steady from 1996 to 2000, percentage of younger beneficiaries with coverage fell to 39 percent from 46 percent; drop leaves many recent retirees without prescription drug coverage; study co-author Bruce Stuart says findings show need for Medicare drug benefit and importance of structuring government coverage in way that helps preserve more generous employer-sponsored coverage (M)", "print_page": "2", "word_count": 703, "_id": "4fd22f158eb7c8105d7bd11c", "snippet": "The number of people retiring with health insurance from their employers has dropped significantly since 1996, according to a new study, leaving many recent retirees without coverage for prescription drugs.    The study, which was conducted from...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/07/23/business/fewer-retirees-are-receiving-drug-benefits-from-employers.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "STUART, BRUCE"}, {"name": "subject", "value": "FRINGE BENEFITS"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Reed", "lastname": "ABELSON"}], "original": "By REED ABELSON"}, "document_type": "article", "pub_date": "2003-07-23T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Eastman Kodak Company, struggling to reinvent itself as digital technology eats into its once-stellar photographic film businesses, said yesterday that it would buy PracticeWorks, a company that sells information technology systems for dental offices, for about $500 million in cash. Analysts said the size of the deal was a clear sign that Kodak had finally accepted that health care-related businesses would be the engine of its future growth, supplanting consumer photography, for decades the bedrock of its profits and its image.", "headline": {"main": "Shifting Its Focus, Kodak Buys Dental Technology Company"}, "abstract": "shifting its focus, kodak buys dental technology com\u00ff", "print_page": "9", "word_count": 861, "_id": "4fd242358eb7c8105d7db2f5", "snippet": "The Eastman Kodak Company, struggling to reinvent itself as digital technology eats into its once-stellar photographic film businesses, said yesterday that it would buy PracticeWorks, a company that sells information technology systems for dental...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/07/22/business/shifting-its-focus-kodak-buys-dental-technology-company.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CARP, DANIEL A"}, {"name": "organizations", "value": "EASTMAN KODAK CO"}, {"name": "organizations", "value": "PRACTICEWORKS"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "TEETH AND DENTISTRY"}, {"name": "subject", "value": "COMPUTERS AND THE INTERNET"}], "byline": {"person": [{"firstname": "Claudia", "middlename": "H.", "lastname": "DEUTSCH", "rank": 1, "role": "reported", "organization": ""}], "original": "By CLAUDIA H. DEUTSCH"}, "document_type": "article", "pub_date": "2003-07-22T00:00:00Z", "section_name": "Technology; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A bill that would make it easier for Americans to import inexpensive prescription medicines from Canada and Europe is gathering support among some Republicans in the House of Representatives, prompting a furious effort by the pharmaceutical industry to defeat the legislation when it comes up for a vote later this week. The so-called ''reimportation'' bill, which would legalize the importation of drugs already sold in the United States, does not have the support of House Republican leaders. They are bringing it up for consideration as part of a deal they struck with a Missouri Republican, Representative Jo Ann Emerson, to secure Mrs. Emerson's vote in favor of a broad Medicare prescription drug benefit, a measure that is a priority of the White House.", "headline": {"main": "MEASURE TO EASE IMPORTS OF DRUGS IS GAINING IN HOUSE"}, "abstract": "Bill to make it easier for Americans to import less expensive prescription drugs from Canada and Europe gains Republican support in House, prompting furious lobbying by pharmaceutical industry; Republican leaders had promised not to fight 'reimportation' bill as part of deal for Rep Jo Ann Emerson's support for broader Medicare drug benefit, but number of colleagues now send they will vote for measure, noting that sales are going on already, have public support and would save taxpayers money; price comparison table; bill would require FDA to set up system allowing individuals, pharmacies and wholesalers in US to buy FDA-approved drugs from industrialized nations (M)", "print_page": "1", "word_count": 1363, "_id": "4fd243858eb7c8105d7dd655", "snippet": "A bill that would make it easier for Americans to import inexpensive prescription medicines from Canada and Europe is gathering support among some Republicans in the House of Representatives, prompting a furious effort by the pharmaceutical industry...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/07/22/us/measure-to-ease-imports-of-drugs-is-gaining-in-house.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "EMERSON, JO ANN"}, {"name": "glocations", "value": "EUROPE"}, {"name": "glocations", "value": "CANADA"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "PUBLIC OPINION"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By SHERYL GAY STOLBERG and GARDINER HARRIS"}, "document_type": "article", "pub_date": "2003-07-22T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 24, "offset": 20, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}